Pharma industry denies it lobbied for medicines to move to DG Enterprise

The European Commission President Jean-Claude Juncker defended in September 2014 his decision to shift the health technology and pharmaceutical policy services back to the more lobby-friendly internal market directorate.

Such move had been criticised by MEPs and NGOs. For its side, the European Federation of Pharmaceutical Industries and Associations (EFPIA) denied it had influenced Mr Juncker's decision.

• Prif ffynhonnell

ESO: Background information: Towards the Juncker Commission http://www.europeansources.info/record/towards-the-juncker-commission/

EUObserver, 30.0914: Juncker defends lobby-friendly restructuring of commission services http://euobserver.com/institutional/125802

---